Biomarker analysis beyond angiogenesis: RAS/RAF mutation status, tumour sidedness, and second-line ramucirumab efficacy in patients with metastatic colorectal carcinoma from RAISE-a global phase III study

  1. Yoshino, T.
  2. Portnoy, D.C.
  3. Obermannová, R.
  4. Bodoky, G.
  5. Prausová, J.
  6. Garcia-Carbonero, R.
  7. Ciuleanu, T.
  8. García-Alfonso, P.
  9. Cohn, A.L.
  10. Van Cutsem, E.
  11. Yamazaki, K.
  12. Lonardi, S.
  13. Muro, K.
  14. Kim, T.W.
  15. Yamaguchi, K.
  16. Grothey, A.
  17. O'Connor, J.
  18. Taieb, J.
  19. Wijayawardana, S.R.
  20. Hozak, R.R.
  21. Nasroulah, F.
  22. Tabernero, J.
Revue:
Annals of Oncology

ISSN: 1569-8041,  0923-7534

Année de publication: 2019

Volumen: 30

Número: 1

Pages: 124-131

Type: Article

DOI: 10.1093/ANNONC/MDY461 GOOGLE SCHOLAR lock_openAccès ouvert editor
La source de données: Scopus